Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Johnson & Johnson (JNJ), The Clorox Co (CLX), The Procter & Gamble Company (PG): Three Companies for the Long Haul

Bonds are not the only viable option for income investors. Today’s low interest rates being paid on government bonds makes dividend-paying stocks a more savvy choice. Combined with dividends, many sound companies increase the initial investment in the form of price appreciation. It’s true that investing in stocks is usually more risky than investing in bonds, but investors can limit their risk almost completely by choosing the right companies.

In this article, I pick three companies for the long haul. One of them comes from the healthcare sector and the other two from the consumer goods sector. These companies have a long history of paying dividends with steady price appreciation, and all three companies have a strong financial position to support their returns. These are Johnson & Johnson (NYSE:JNJ), The Clorox Co (NYSE:CLX), and The Procter & Gamble Company (NYSE:PG). Let’s review each company’s ability to sustain its returns.

Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson’s returns

Johnson & Johnson (NYSE:JNJ) is engaged in the development, manufacture, and sale of an array of products in the healthcare sector. It has shown a solid track record, and it has been able to increase its dividends consistently over the past 51 years. Along with consistently increasing income, in the past five years its share price has increased by 33.1%.

Are these returns safe?

Johnson & Johnson (NYSE:JNJ) is a strong company with a great deal of diversification. Its investments to advance its pipelines and enlarge its worldwide presence have enabled it to generate increased earnings over the past 39 years. Johnson & Johnson (NYSE:JNJ) recently announced Q1 results with the success of recently launched pharmaceutical products, including INVEGA, SUSTENNA, and XEPLION.

Johnson & Johnson (NYSE:JNJ)’s top-line growth is staggering. At the end of Q1, its sales increased by 8.5% over the past year’s quarter. With solid top-line growth, it has hefty margins on sales. As a result, its net earnings for the recent quarter stand at $4.1 billion or $1.44 per share, an increase of 8.0%. Johnson & Johnson (NYSE:JNJ) is anticipating generating EPS of between $5.35 and $5.45 by the end of 2013.

With a solid pipeline and strong earnings, it has the potential to generate exceptional cash flow. In the trailing-12 months, its free cash flow stands at $12 billion while dividends account for only $7 billion. Its dividend looks safe as its free cash flow provides full coverage to dividends. Along with other financial indicators, its P/CF ratio of 16.1 also suggests its ability to sustain dividends.

Procter & Gamble’s returns

The Procter & Gamble Company (NYSE:PG) offers branded consumer packaged goods. Currently, The Procter & Gamble Company (NYSE:PG) offers a quarterly dividend of $0.60, yielding at 3.0%. In the past five years, it has been able to raise its dividends by 50.4%. With healthy dividends, the stock has also shown a strong surge with a few shortfalls.

Are the returns safe?

The Procter & Gamble Company (NYSE:PG) is one of the best stocks in the consumer goods sector. The company has shown solid top-line growth over the years. As the global market share trends are improving, the company continues implementing its growth strategy. As a result, its organic sales grew by 3% over the past year’s quarter. Along with improving top-line growth, the company is looking to enhance margins.

Recently, it announced a $10 billion cost-saving plan to enhance margins and reduce operational costs. As a result, at the end of the recent quarter, its core gross margin was enlarged by 20 basis points and its core operating profit margin was enlarged by 10 basis points.

The Procter & Gamble Company (NYSE:PG)’s financial situation looks stable enough to sustain returns for investors as its free cash flow provides adequate cover to pay its dividends. In the trailing-12 months, it had generated $11 billion in free cash flow when dividends accounted for only $6 billion. Additionally, The Procter & Gamble Company (NYSE:PG) has a low debt-to-equity ratio of 0.3, which also symbolizes its ability to sustain dividend. With the payout ratio of 56%, P&G has a room to increase its dividends.

Clorox’s dividends

The Clorox Co (NYSE:CLX) manufactures and markets consumer and institutional products worldwide. It has been paying consistently increasing dividends for a consecutive 36 years. Recently, it announced an increase of 10.9% in dividends–this takes its quarterly dividend to $0.71 per share.

Are the dividends safe?

The Clorox Co (NYSE:CLX) has a strong brand name, which means it has the capacity to transfer commodity price increases to consumers. The Clorox Co (NYSE:CLX) is seeking to grow earnings by innovative new product launches along with international expansion. Based on its centennial strategy, it is anticipating achieving double-digit annual growth in economic profit. To this purpose, its strategy to increase sales includes expanding into adjacent categories, growing existing brands, and entering new sales channels.

Recently, the company announced Q3 results with a 1% growth in sales. Its quarterly results were impacted by charcoal volume and sales due to unfavorable weather conditions. However, The Clorox Co (NYSE:CLX) is expecting to generate an EPS of $4.30 in 2013 and $4.63 in 2014. I believe its dividends are safe as Clorox is seeking to sustain its profitability momentum.

Additionally, this company has very solid cash flow, and its free cash flow is  providing full coverage to its dividends. In the trailing-12 months, its free cash flow stands at $565 million while dividends accounted for only $328 million. Its payout ratio of 59% is also manageable. Its current and quick ratios of 1.2 and 0.7 also indicate no sign of excessive debt burdens. The Clorox Co (NYSE:CLX) have sufficient funds to meet current liabilities.

In conclusion

Johnson & Johnson (NYSE:JNJ) is a solid pick for investors. The company’s investment to advance pipelines and enlarge its worldwide presence along with good diversification permits it to sustain returns for investors. Clorox is a solid company for defensive investors. Clorox has a strong brand with strong growth opportunities. The Clorox Co (NYSE:CLX) is in a strong financial situation to sustain returns for investors. Finally, in the case of The Procter & Gamble Company (NYSE:PG), it is a buy for the long haul. P&G is in a strong financial situation that will be further enhanced as the company implements its cost-reduction plan.

The article 3 Companies for the Long Haul originally appeared on Fool.com and is written by siraj sarwar.

siraj sarwar has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson and Procter & Gamble. The Motley Fool owns shares of Johnson & Johnson. siraj is a member of The Motley Fool Blog Network — entries represent the personal opinion of the blogger and are not formally edited.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.